The benefits of timely intervention with zoledronic acid in patients with metastatic prostate cancer to bones: a retrospective study of the US Veterans Affairs population

Abstract

To examine the effect of timely zoledronic acid (ZA) treatment on clinical outcomes and health care utilization in patients with bone-metastatic prostate cancer. Patients with prostate cancer and bone metastasis were identified in a Veterans Affairs database (01/2002–09/2009). Eligible patients had no documented skeletal-related events (SREs) before the… (More)
DOI: 10.1038/pcan.2010.49

Topics

5 Figures and Tables

Cite this paper

@article{Velde2011TheBO, title={The benefits of timely intervention with zoledronic acid in patients with metastatic prostate cancer to bones: a retrospective study of the US Veterans Affairs population}, author={Nancy Vander Velde and Eric Qiong Wu and Amy Guo and M J Lu and Andrew Peng Yu and Hirsh Sharma and J Liu and Chun Po Steve Fan and L Shi}, journal={Prostate Cancer and Prostatic Diseases}, year={2011}, volume={14}, pages={79-84} }